GP
GreenPower Motor Company Inc.
There isn't enough reported data to score GP yet.
RIVN
Rivian Automotive, Inc.
RIVN lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
GP Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Weak | |
| Unavailable |
GP's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
GP PE Valuation
GP has no meaningful PE right now: it lost money over the past year.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
GP Forward outlook
There aren't enough analyst estimates for GP to show an outlook.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
GP Earnings Per Share
GP and RIVN do not have enough comparable growth data to identify a winner.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
GP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $439.1K | -72% |
| Q1 2026 | $3.9M | -10% |
| Q4 2025 | $8.5M | +18% |
| Q3 2025 | $2.5M | -53% |
| Q2 2025 | $1.5M | -48% |
| Q1 2025 | $4.3M | -16% |
| Q4 2024 | $7.2M | -12% |
| Q3 2024 | $5.3M | -37% |
GP's revenue has slid since its 2023 peak: $439,148 last quarter, down 72% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -367% | -136 points |
| Q1 2026 | 1.7% | +129 points |
| Q4 2025 | 58% | N/A |
| Q3 2025 | -118% | N/A |
| Q2 2025 | -231% | N/A |
| Q1 2025 | -127% | N/A |
| Q4 2023 | -53% | -30 points |
| Q3 2023 | -47% | -7.3 points |
GP's operating margin was −367% last quarter, down 136 points from the same quarter a year ago, near the bottom of its range since 2019.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over GP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN has the edge over GP on profitability, with a higher operating margin.
GP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.3M | +$111.7K |
| Q1 2026 | -$3.7M | -$3.3M |
| Q4 2025 | -$1.2M | -$131.2K |
| Q3 2025 | $173.2K | +$1.5M |
| Q2 2025 | -$1.4M | +$1.9M |
| Q1 2025 | -$390.8K | +$4.6M |
| Q4 2024 | -$1.1M | -186% |
| Q3 2024 | -$1.4M | +$4.1M |
GP has the edge over RIVN on cash flow, with more consistent year-over-year improvement.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
GP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +99% | +562K shares |
| 1 year | +127% | +633K shares |
GP has 1M diluted shares, up 127% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2023 | — |
| Q3 2023 | — |
GP hasn't bought back shares in the past year.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has the edge over GP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
GP Net Leverage
GP's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.6 | Neutral |
| Stochastic | 3.8 | Oversold |
GP's weekly RSI is 31 (neutral) and its Stochastic is 4 (oversold).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
GP PE vs Consumer Cyclical Sector
GP has no meaningful PE right now: it lost money over the past year.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
GP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.70 | 28% below |
| 20 week MA | $4.72 | 74% below |
| 50 week MA | $5.04 | 76% below |
| 100 week MA | $14.0 | 91% below |
| 200 week MA | $64.0 | 98% below |
GP is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
GP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $76.7 | $1,134.5 | +1380% |
| 2021 | $1,134.5 | $443.0 | -61% |
| 2022 | $443.0 | $96.5 | -78% |
| 2023 | $96.5 | $156.5 | +62% |
| 2024 | $156.5 | $37.9 | -76% |
| 2025 | $37.9 | $4.17 | -89% |
| 2026 YTD | $4.17 | $1.23 | -71% |
GP's yearly returns have swung widely, from +1380% in 2020 to −89% in 2025. It's down 71% so far in 2026.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has the edge over GP on returns for 2026, with the stronger performance.